Metropolitan Life Insurance Company (MetLife)’s Camden National CAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-809
| Closed | -$27.1K | – | 352 |
|
|
2024
Q1 | $27.1K | Hold |
809
| – | – | ﹤0.01% | 1710 |
|
|
2023
Q4 | $30.4K | Hold |
809
| – | – | ﹤0.01% | 1712 |
|
|
2023
Q3 | $22.8K | Hold |
809
| – | – | ﹤0.01% | 1823 |
|
|
2023
Q2 | $25.1K | Hold |
809
| – | – | ﹤0.01% | 1814 |
|
|
2023
Q1 | $29.3K | Hold |
809
| – | – | ﹤0.01% | 1698 |
|
|
2022
Q4 | $33.7K | Hold |
809
| – | – | ﹤0.01% | 1720 |
|
|
2022
Q3 | $34.5K | Hold |
809
| – | – | ﹤0.01% | 1712 |
|
|
2022
Q2 | $35.6K | Hold |
809
| – | – | ﹤0.01% | 1711 |
|
|
2022
Q1 | $38.1K | Sell |
809
-3,042
| -79% | -$150K | ﹤0.01% | 1741 |
|
|
2021
Q4 | $185K | Hold |
3,851
| – | – | ﹤0.01% | 2079 |
|
|
2021
Q3 | $184K | Sell |
3,851
-1,027
| -21% | -$47.3K | ﹤0.01% | 2140 |
|
|
2021
Q2 | $233K | Buy |
4,878
+303
| +7% | +$14.4K | ﹤0.01% | 2035 |
|
|
2021
Q1 | $219K | Sell |
4,575
-315
| -6% | -$13.2K | ﹤0.01% | 1955 |
|
|
2020
Q4 | $175K | Hold |
4,890
| – | – | ﹤0.01% | 2020 |
|
|
2020
Q3 | $148K | Hold |
4,890
| – | – | ﹤0.01% | 1973 |
|
|
2020
Q2 | $169K | Hold |
4,890
| – | – | ﹤0.01% | 1917 |
|
|
2020
Q1 | $154K | Hold |
4,890
| – | – | ﹤0.01% | 1754 |
|
|
2019
Q4 | $225K | Hold |
4,890
| – | – | ﹤0.01% | 1833 |
|
|
2019
Q3 | $212K | Hold |
4,890
| – | – | ﹤0.01% | 1837 |
|
|
2019
Q2 | $224K | Hold |
4,890
| – | – | ﹤0.01% | 1822 |
|
|
2019
Q1 | $204K | Hold |
4,890
| – | – | ﹤0.01% | 1890 |
|
|
2018
Q4 | $176K | Hold |
4,890
| – | – | ﹤0.01% | 1906 |
|
|
2018
Q3 | $212K | Hold |
4,890
| – | – | ﹤0.01% | 1971 |
|
|
2018
Q2 | $224K | Hold |
4,890
| – | – | ﹤0.01% | 1877 |
|
|
2018
Q1 | $218K | Hold |
4,890
| – | – | ﹤0.01% | 1843 |
|
|
2017
Q4 | $206K | Sell |
4,890
-5,920
| -55% | -$258K | ﹤0.01% | 1890 |
|
|
2017
Q3 | $472K | Hold |
10,810
| – | – | ﹤0.01% | 1727 |
|
|
2017
Q2 | $464K | Hold |
10,810
| – | – | ﹤0.01% | 1744 |
|
|
2017
Q1 | $476K | Sell |
10,810
-676
| -6% | -$28.7K | ﹤0.01% | 1679 |
|
|
2016
Q4 | $511K | Sell |
11,486
-1
| -0% | -$37 | ﹤0.01% | 1709 |
|
|
2016
Q3 | $366K | Hold |
11,487
| – | – | ﹤0.01% | 1911 |
|
|
2016
Q2 | $322K | Buy |
11,487
+2,647
| +30% | +$75.2K | ﹤0.01% | 1978 |
|
|
2016
Q1 | $248K | Buy |
8,840
+17
| +0.2% | +$457 | ﹤0.01% | 2046 |
|
|
2015
Q4 | $259K | Hold |
8,823
| – | – | ﹤0.01% | 2064 |
|
|
2015
Q3 | $238K | Sell |
8,823
-629
| -7% | -$16.8K | ﹤0.01% | 2157 |
|
|
2015
Q2 | $244K | Buy |
9,452
+357
| +4% | +$9.26K | ﹤0.01% | 2265 |
|
|
2015
Q1 | $242K | Hold |
9,095
| – | – | ﹤0.01% | 1967 |
|
|
2014
Q4 | $242K | Hold |
9,095
| – | – | ﹤0.01% | 2275 |
|
|
2014
Q3 | $212K | Hold |
9,095
| – | – | ﹤0.01% | 2328 |
|
|
2014
Q2 | $235K | Hold |
9,095
| – | – | ﹤0.01% | 2394 |
|
|
2014
Q1 | $250K | Hold |
9,095
| – | – | ﹤0.01% | 2308 |
|
|
2013
Q4 | $256K | Hold |
9,095
| – | – | ﹤0.01% | 2301 |
|
|
2013
Q3 | $248K | Hold |
9,095
| – | – | ﹤0.01% | 2257 |
|
|
2013
Q2 | $215K | Buy |
+9,095
| New | +$211K | ﹤0.01% | 2302 |
|
Other funds holding CAC
BCM
Metropolitan Life Insurance Company (MetLife)'s CAC Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Camden National (CAC) in Q2 2024, closing a stake of 809 shares — an estimated $27.1K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in CAC in Q2 2013 and held it in 44 quarters. The position peaked at $511K in Q4 2016. 131 funds tracked by Wall St. Rank hold CAC as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Camden National position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 809 Camden National shares in Q2 2024, an estimated $27.1K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Camden National in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Camden National position peaked at $511K in Q4 2016.
- 131 funds tracked by Wall St. Rank held Camden National as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.